IMGN Immunogen Inc

Immunogen Inc is a clinical-stage biotechnology company that develops targeted anticancer therapeutics. It has developed its ADC technology to enable the creation of anticancer products.

$5.46  +0.19 (3.61%)
As of 12/02/2022 15:59:59 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/20/2001
Outstanding shares:  220,750,928
Average volume:  4,561,298
Market cap:   $1,163,357,391
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      2457864
Valuation   (See tab for details)
PE ratio:   -9.33
PB ratio:   3.94
PS ratio:   12.61
Return on equity:   -42.22%
Net income %:   -140.30%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy